| Literature DB >> 28338752 |
Leah M Smith1,2, Linda E Lévesque2,3, Jay S Kaufman1, Erin C Strumpf1,4.
Abstract
Background: The regression discontinuity design (RDD) is a quasi-experimental approach used to avoid confounding bias in the assessment of new policies and interventions. It is applied specifically in situations where individuals are assigned to a policy/intervention based on whether they are above or below a pre-specified cut-off on a continuously measured variable, such as birth date, income or weight. The strength of the design is that, provided individuals do not manipulate the value of this variable, assignment to the policy/intervention is considered as good as random for individuals close to the cut-off. Despite its popularity in fields like economics, the RDD remains relatively unknown in epidemiology where its application could be tremendously useful.Entities:
Keywords: HPV vaccine; causality; cohort studies; epidemiologic research design; human papillomavirus; regression discontinuity design
Mesh:
Substances:
Year: 2017 PMID: 28338752 PMCID: PMC5837477 DOI: 10.1093/ije/dyw195
Source DB: PubMed Journal: Int J Epidemiol ISSN: 0300-5771 Impact factor: 7.196
Figure 1.Hypothetical RDD setting. (a) Sharp exposure discontinuity; (b) fuzzy exposure discontinuity; (c) outcome discontinuity.
Operationalization of forcing variable
| Grade 8 school year | Birth year | Birth year quarter | Value of forcing variable | |
|---|---|---|---|---|
| Ineligible | Mar 1992–Jan 1992 | –8 | ||
| 2005/06 | 1992 | Jun 1992–Apr 1992 | –7 | |
| Sept 1992–Jul 1992 | –6 | |||
| Dec 1992–Oct 1992 | –5 | |||
| Mar 1993–Jan 1993 | –4 | |||
| 2006/07 | 1993 | Jun 1993–Apr 1993 | –3 | |
| Sept 1993–Jul 1993 | –2 | |||
| Dec 1993–Oct 1993 | –1 | |||
| Eligible | Jan 1994–Mar 1994 | 0 | ||
| 2007/08 | 1994 | Apr 1994–Jun 1994 | 1 | |
| Jul 1994–Sept 1994 | 2 | |||
| Oct 1994–Dec 1994 | 3 | |||
| Jan 1995–Mar 1995 | 4 | |||
| 2008/09 | 1995 | Apr 1995–Jun 1995 | 5 | |
| Jul 1995–Sept 1995 | 6 | |||
| Oct 1995–Dec 1995 | 7 |
Figure 2.Probability of exposure, by the forcing variable*. (a) Probability of qHPV vaccine programme eligibility; (b) probability of qHPV vaccination. *See Table 1 for how values of the forcing variable were operationalized.
Distribution of cohort members across birth year quarters (forcing variable)
| Forcing variable | Frequency | Percentage ( |
|---|---|---|
| –8 | 16 309 | 6.26 |
| –7 | 17 415 | 6.69 |
| –6 | 17 126 | 6.57 |
| –5 | 15 803 | 6.07 |
| –4 | 15 766 | 6.05 |
| –3 | 17 035 | 6.54 |
| –2 | 16 697 | 6.41 |
| –1 | 15 630 | 6.00 |
| 0 | 15 741 | 6.04 |
| 1 | 16 860 | 6.47 |
| 2 | 16 695 | 6.41 |
| 3 | 15 522 | 5.96 |
| 4 | 15 419 | 5.92 |
| 5 | 16 743 | 6.43 |
| 6 | 16 561 | 6.36 |
| 7 | 15 171 | 5.82 |
Figure 3.Density of the forcing variable. *See Table 1 for how values of the forcing variable were operationalized.
Figure 4.Distribution of selected baseline characteristics, by forcing variable. (a) Rural residency; (b) Previous MMR vaccination; (c) Previous hepatitis B vaccination; (d) 0–1 outpatient physician visits; (e) Cancer; (f) Sexual history.
Figure 5.Risk of outcome (cervical dysplasia). (a) Probability of outcome, by forcing variable*; (b) Probability of outcome, by birth year. *See Table 1 for how values of the forcing variable were operationalized.